API Product Detail
Home API Fidaxomicin CS-O-30824

Fidaxomicin

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-O-30824 API Research Use Only
Fidaxomicin
Category
API
API Family
Fidaxomicin
Product Code
CS-O-30824
Research Status
For Laboratory Use

Fidaxomicin

Fidaxomicin API
Stock Status: In Stock
Live

CAT No.
CS-O-30824
CAS No.
873857-62-6
Molecular Formula
C₅₂H₇₄Cl₂O₁₈
Molecular Weight
1058.04
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
873857-62-6
Product Code
CS-O-30824
M.F.
C₅₂H₇₄Cl₂O₁₈
M.W.
1058.04
Smiles
O=C(O[C@@H]1[C@@H](C)O[C@@H](OC/C2=C/C=C/C[C@H](O)/C(C)=C\[C@H](CC)[C@@H](O[C@H]3[C@@H](O)[C@@H](O)[C@H](OC(C(C)C)=O)C(C)(C)O3)/C(C)=C/C(C)=C/C[C@@H]([C@H](O)C)OC2=O)[C@@H](OC)[C@H]1O)C4=C(O)C(Cl)=C(O)C(Cl)=C4CC
Category
API
API Family
Fidaxomicin
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
(2R,3S,4S,5S,6R)-6-(((3Z,5E,8S,9Z,11S,12R,13E,15E,18S)-12-(((2R,3S,4R,5S)-3,4-dihydroxy-5-(isobutyryloxy)-6,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-ethyl-8-hydroxy-18-((R)-1-hydroxyethyl)-9,13,15-trimethyl-2-oxooxacyclooctadeca-3,5,9,13,15-pentaen-3-yl)methoxy)-4-hydroxy-5-methoxy-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate
References
Synonyms
Not available
Application Notes
"Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen." "Babakhani; F,; et al,:clin, Infct, Dis,; 55; S162 (2012); Venugopal; A,; et al,:clin, Infct, Dis,; 54; 568 (2012)"
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Overview
"Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen." "Babakhani; F,; et al,:clin, Infct, Dis,; 55; S162 (2012); Venugopal; A,; et al,:clin, Infct, Dis,; 54; 568 (2012)"

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.